GO:0086045 membrane depolarization during AV node cell action potential: Electrophysiology Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0086045 describes the depolarizing phase of the action potential specifically in atrioventricular (AV) node cardiac muscle cells, from the negative resting potential toward the peak of the action potential.
• AV node cells are unique among cardiac cells because their depolarization depends on a slow, Ca2+-dependent inward current rather than the fast Na+ current that drives atrial and ventricular depolarization.
• The AV node acts as the electrical gate between atria and ventricles, and its depolarization properties determine conduction velocity and heart rate.
• Spontaneous depolarization in AV node cells is modulated by intracellular signaling molecules such as inositol trisphosphate (IP3), which can alter action potential firing rate.
• Dysregulation of AV node depolarization underlies clinically important arrhythmias including AV block, Wenckebach periodicity, and reentrant tachycardias.
• CRISPR-based knockout, point-mutation, and knock-in models in iPSC-derived cardiomyocytes or animal models enable causal testing of genes regulating AV node depolarization.
Description
The atrioventricular (AV) node is a specialized cluster of cardiac muscle cells that serves as the sole electrical conduit between the atria and ventricles. Unlike working myocardium, AV node cells exhibit slow, spontaneous depolarization that depends on a distinct complement of ion channels and transporters. The Gene Ontology term GO:0086045, membrane depolarization during AV node cell action potential, captures the specific biological process by which the membrane potential of an AV node cardiac muscle cell moves in the depolarizing direction from its negative resting potential toward the peak of the action potential. This process is fundamental to normal cardiac rhythm and conduction, and its perturbation is linked to a range of arrhythmic disorders. For researchers, GO:0086045 provides a precise ontological handle for annotating genes and pathways that contribute to the depolarizing phase of AV node action potentials. The AV node depolarization is driven largely by inward Ca2+ current through L-type and T-type calcium channels, with contributions from other currents that are still being defined. Recent work has shown that intracellular signaling via inositol trisphosphate (IP3) can modulate the spontaneous action potential rate in AV node myocytes, highlighting the integration of metabolic and electrical signals in this tissue. Understanding the molecular players in AV node depolarization is essential for developing targeted therapies for conduction disorders and for interpreting genetic variants associated with arrhythmia risk. This article synthesizes authoritative QuickGO annotation data and verified PubMed literature to provide a research-grade overview of GO:0086045. We cover the definition, mechanistic stages, key genes, regulatory inputs, disease relevance, and experimental models including CRISPR-based approaches. The goal is to equip biomedical researchers with a clear, citable resource for studying AV node depolarization and its role in cardiac electrophysiology.
membrane depolarization during AV node cell action potential At A Glance
| GO ID | GO:0086045 |
|---|---|
| GO term | membrane depolarization during AV node cell action potential |
| Ontology | biological_process |
| Synonym | membrane depolarization during atrioventricular node cardiac muscle cell action potential; membrane depolarization during AV node cardiac muscle cell action potential |
| Major function | Generation of the depolarizing (rising) phase of the action potential in AV node cardiac muscle cells, enabling electrical conduction from atria to ventricles. |
| Cellular location | Plasma membrane of AV node cardiac muscle cells. |
| Key ion currents | Inward Ca2+ current (L-type and T-type), plus contributions from other currents; fast Na+ current is largely absent. |
| Physiological role | Determines AV nodal conduction velocity and contributes to rate control and the AV delay. |
| Modulation | Regulated by autonomic tone, intracellular IP3 signaling, and other second messengers. |
What Is GO:0086045?
GO:0086045, membrane depolarization during AV node cell action potential, is defined as the process in which AV node cardiac muscle cell membrane potential changes in the depolarizing direction from the negative resting potential towards the positive membrane potential that will be the peak of the action potential. In simpler terms, it is the rising phase of the electrical signal in the specialized cells of the AV node, the heart's electrical relay station. This process is distinct from depolarization in atrial or ventricular myocytes because AV node cells rely on slow inward calcium currents rather than fast sodium currents.
Why Is membrane depolarization during AV node cell action potential Important in Cell Biology?
GO:0086045 is critically important because the AV node is the only normal electrical connection between the atria and ventricles, and its depolarization properties set the conduction speed and rhythm of the heart. Abnormal depolarization of AV node cells can lead to bradyarrhythmias, AV block, and tachyarrhythmias, making this process a key target for antiarrhythmic drug development and a focus for understanding inherited conduction disorders. Moreover, the unique ionic mechanisms of AV node depolarization distinguish it from working myocardium, offering opportunities for selective pharmacological or genetic modulation.
• The AV node is the sole normal electrical pathway from atria to ventricles; its depolarization determines the AV delay and ventricular rate.
• AV node depolarization relies on slow Ca2+ currents, making it sensitive to calcium channel blockers and other antiarrhythmic agents.
• Dysfunction of AV node depolarization contributes to clinical conditions such as Wenckebach periodicity and complete heart block.
• Spontaneous depolarization in AV node cells can be modulated by IP3, linking cellular signaling to pacemaker activity.
• Genetic variants affecting ion channels in the AV node are associated with inherited arrhythmia syndromes.
• Understanding AV node depolarization is essential for developing safe and effective rate-control therapies.
• AV node cells are a target for gene therapy and CRISPR-based approaches to correct conduction defects.
• The unique electrophysiology of AV node cells makes them a model for studying slow-response action potentials.
• Research on AV node depolarization informs the design of biological pacemakers.
• GO:0086045 provides a standardized annotation for comparative and functional genomics studies of cardiac conduction.
What Happens During membrane depolarization during AV node cell action potential?
Initiation from the resting potential
In simple terms: The AV node cell starts at a negative resting voltage, and then something makes it begin to become more positive.
AV node cardiac muscle cells have a relatively depolarized resting membrane potential compared to ventricular myocytes, typically around -60 to -70 mV. Depolarization begins when the membrane potential reaches the threshold for activation of inward currents. In AV node cells, this threshold is reached either spontaneously (as in pacemaker activity) or following electrical input from the atrium. The initial depolarizing stimulus is primarily carried by inward calcium currents, since the fast sodium current is largely absent in these cells.
Activation of slow inward calcium current
In simple terms: Calcium ions flow into the cell, making the inside more positive and driving the rising phase of the signal.
The upstroke of the AV node action potential is predominantly mediated by inward Ca2+ current through L-type (Cav1.2, Cav1.3) and T-type (Cav3.1, Cav3.2) calcium channels. These channels activate slowly compared to voltage-gated sodium channels, resulting in a slower depolarization rate and slower conduction velocity in the AV node. The balance between inward Ca2+ current and outward K+ currents determines the slope of depolarization and the peak potential achieved.
Contribution of other ion currents
In simple terms: Other ion channels also help shape the rising phase, fine-tuning the speed and height of depolarization.
In addition to Ca2+ currents, a small persistent inward Na+ current and the funny current (If) may contribute to depolarization in AV node cells, particularly during spontaneous activity. Outward potassium currents, such as IKr and IKs, oppose depolarization and influence the action potential duration. The interplay of these currents is complex and varies across species and developmental stages.
Reaching the peak and transition to repolarization
In simple terms: Once the cell reaches its most positive voltage, the depolarization phase ends and the cell begins to reset.
Depolarization continues until the inward currents are balanced by outward currents and inactivation of calcium channels, marking the peak of the action potential. At this point, the process of repolarization begins, returning the cell to its resting state. The peak potential and the duration of depolarization are critical determinants of AV nodal conduction and refractoriness.
Modulation by intracellular signaling
In simple terms: Signals inside the cell can change how easily the AV node cell depolarizes, affecting heart rate.
Recent evidence indicates that inositol trisphosphate (IP3) signaling can modulate the spontaneous action potential rate in AV node myocytes, suggesting that G-protein-coupled receptor pathways and intracellular Ca2+ release influence depolarization. This adds a layer of regulation beyond membrane ion channels, linking metabolic and neurohormonal signals to AV node excitability.
Key Genes Involved in GO:0086045 membrane depolarization during AV node cell action potential
The following genes encode ion channels, transporters, and signaling proteins that contribute to or regulate membrane depolarization during AV node cell action potential (GO:0086045).
| Gene | Major Role | Research Relevance |
|---|---|---|
| CACNA1C | Encodes Cav1.2, the pore-forming subunit of L-type calcium channels mediating the main inward Ca2+ current during AV node depolarization. | Target for calcium channel blockers; mutations linked to Timothy syndrome and Brugada syndrome. |
| CACNA1D | Encodes Cav1.3, another L-type calcium channel subunit contributing to AV node depolarization. | Implicated in sinoatrial and AV node dysfunction; potential target for pacemaker research. |
| CACNA1G | Encodes Cav3.1, a T-type calcium channel involved in low-threshold depolarization. | Modulates AV node automaticity; studied in arrhythmia models. |
| CACNA1H | Encodes Cav3.2, T-type calcium channel contributing to depolarization in AV node cells. | Potential role in AV nodal reentrant tachycardia; target for T-type blockers. |
| HCN4 | Encodes the hyperpolarization-activated cyclic nucleotide-gated channel underlying If, which can contribute to depolarization. | Major pacemaker channel; mutations cause sinus node dysfunction and AV block. |
| SCN5A | Encodes Nav1.5, the cardiac sodium channel; although fast Na+ current is low in AV node, it may contribute to depolarization under some conditions. | Mutations cause Brugada syndrome, LQT3, and conduction disease. |
| KCNH2 | Encodes hERG (Kv11.1), a potassium channel that opposes depolarization and shapes action potential. | Target of class III antiarrhythmics; mutations cause LQT2. |
| KCNQ1 | Encodes Kv7.1, a potassium channel contributing to repolarization and indirectly influencing depolarization. | Mutations cause LQT1 and Jervell-Lange-Nielsen syndrome. |
| KCNJ2 | Encodes Kir2.1, an inward rectifier K+ channel setting resting potential. | Mutations cause Andersen-Tawil syndrome; affects AV node excitability. |
| ITPR1 | Encodes IP3 receptor type 1, mediating intracellular Ca2+ release that can modulate AV node depolarization. | IP3 signaling modulates spontaneous action potential rate in AV node myocytes. |
| ITPR2 | Encodes IP3 receptor type 2, another IP3 receptor involved in Ca2+ signaling. | Potential role in AV node pacemaker activity. |
| PLCB1 | Encodes phospholipase C beta 1, generating IP3 and DAG upon Gq-coupled receptor activation. | Links autonomic signaling to AV node depolarization. |
| ADRB1 | Encodes beta-1 adrenergic receptor, which enhances AV node conduction via cAMP/PKA signaling. | Target of beta-blockers for rate control. |
| ADRB2 | Encodes beta-2 adrenergic receptor, also expressed in AV node and modulating depolarization. | Contributes to sympathetic regulation of AV nodal conduction. |
| CHRM2 | Encodes M2 muscarinic receptor, mediating vagal slowing of AV node depolarization. | Target of vagal maneuvers and anticholinergic drugs. |
| GJA1 | Encodes connexin 43, a gap junction protein affecting cell-to-cell coupling in AV node. | Altered expression affects conduction velocity. |
| GJA5 | Encodes connexin 40, a gap junction protein important for AV node conduction. | Polymorphisms linked to atrial fibrillation. |
| RYR2 | Encodes ryanodine receptor 2, mediating sarcoplasmic reticulum Ca2+ release that can influence depolarization. | Mutations cause CPVT; crosstalk with AV node Ca2+ signaling. |
How Is membrane depolarization during AV node cell action potential Regulated?
The depolarization phase of the AV node action potential is regulated by multiple mechanisms. Autonomic neurotransmitters, such as norepinephrine acting on beta-adrenergic receptors and acetylcholine acting on muscarinic receptors, modulate the activity of calcium and potassium channels, thereby altering the slope of depolarization and conduction velocity. Intracellular signaling pathways, including the IP3 pathway, can influence spontaneous depolarization by promoting Ca2+ release from internal stores. Additionally, phosphorylation of ion channels by protein kinases such as PKA and CaMKII can modify their gating properties, affecting the rate of depolarization. These regulatory inputs ensure that AV node conduction adapts to physiological demands and can be disrupted in disease states.
membrane depolarization during AV node cell action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCN5A | Brugada syndrome, progressive cardiac conduction disease, AV block | Knockout or point-mutation knock-in in iPSC-derived cardiomyocytes or mouse models |
| HCN4 | Sinus node dysfunction, AV block, bradycardia | Knock-in of patient mutations in hiPSCs; electrophysiological phenotyping |
| CACNA1C | Timothy syndrome, Brugada syndrome, AV conduction defects | CRISPR point mutation to introduce gain-of-function variants; patch-clamp analysis |
| KCNH2 | Long QT syndrome type 2, arrhythmia risk | Knockout or overexpression in cardiomyocytes; action potential duration assays |
| ITPR1 | Modulation of AV node spontaneous activity | Knockout in AV node-like cells; IP3 signaling and pacemaker activity assays |
Atrioventricular block and conduction disorders
Impaired depolarization of AV node cells can lead to first-, second-, or third-degree AV block, where electrical signals from the atria fail to reach the ventricles properly. Wenckebach periodicity, a form of second-degree AV block, is characterized by progressive prolongation of AV conduction until a beat is dropped, reflecting the unique decremental conduction properties of the AV node. Genetic variants in ion channel genes such as SCN5A and HCN4 have been associated with inherited AV block.
Supraventricular tachycardias
Abnormal depolarization and conduction within the AV node can create the substrate for reentrant arrhythmias, including AV nodal reentrant tachycardia (AVNRT), the most common form of supraventricular tachycardia. Dual AV nodal pathways with different depolarization properties can form a reentrant circuit, leading to paroxysmal tachycardia. Understanding the ionic basis of AV node depolarization is essential for developing targeted antiarrhythmic therapies.
Heart failure and autonomic dysfunction
In heart failure, altered autonomic tone and ion channel remodeling can affect AV node depolarization, contributing to conduction abnormalities and arrhythmia risk. Beta-blockers and other agents that modulate AV node depolarization are mainstays of heart failure therapy. Research into the molecular regulation of AV node depolarization may reveal new therapeutic targets.
From membrane depolarization during AV node cell action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CACNA1C abolish AV node depolarization? | CRISPR knockout of CACNA1C in iPSC-derived AV node-like cardiomyocytes |
| Does a specific SCN5A variant alter AV node conduction? | Point-mutation knock-in of the variant in hiPSCs followed by microelectrode array analysis |
| Can overexpression of HCN4 enhance spontaneous AV node depolarization? | Lentiviral overexpression of HCN4 in AV node cells or in vivo gene transfer |
| What is the role of IP3 receptors in AV node pacemaker activity? | Knockout of ITPR1/ITPR2 in AV node myocytes; calcium imaging and action potential recordings |
| How do gap junction proteins affect AV node conduction? | Knock-in of tagged GJA1 or GJA5 to track localization and function |
| Can CRISPR activation of KCNQ1 shorten AV node action potential? | CRISPRa overexpression of KCNQ1 in AV node cells; patch-clamp electrophysiology |
How to Study the membrane depolarization during AV node cell action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ionic currents, action potential parameters | Assess depolarization rate and ion channel contributions in AV node cells |
| Optical mapping | Action potential propagation and conduction velocity | Study AV node conduction and arrhythmia mechanisms |
| Calcium imaging | Intracellular Ca2+ transients | Investigate Ca2+-dependent depolarization and IP3 signaling |
| RNA-seq | Gene expression profiles | Identify ion channels and signaling genes in AV node tissue |
| Proteomics | Protein abundance and modifications | Detect channel phosphorylation and regulatory proteins |
| Microelectrode array (MEA) | Extracellular field potentials | High-throughput phenotyping of hiPSC-derived AV node cells |
| CRISPR screening | Gene function at scale | Discover novel regulators of AV node depolarization |
| FRET biosensors | cAMP, PKA activity, voltage | Monitor real-time signaling in AV node cells |
Patch-clamp electrophysiology
Patch-clamp recording is the gold standard for measuring ionic currents and action potentials in AV node cells. It allows direct quantification of the depolarization rate, threshold, and peak potential, as well as the contributions of specific ion channels. This method can be applied to isolated AV node myocytes or hiPSC-derived cardiomyocytes to assess the effects of genetic manipulations.
Optical mapping and voltage-sensitive dyes
Optical mapping using voltage-sensitive dyes enables non-invasive measurement of action potential propagation in AV node tissue or engineered cardiac tissues. It can reveal conduction velocity, depolarization patterns, and arrhythmia dynamics. This technique is particularly useful for studying the AV node in intact preparations or organoids.
Calcium imaging
Calcium imaging with fluorescent indicators (e.g., Fluo-4) visualizes intracellular Ca2+ transients that accompany depolarization. It can assess the role of Ca2+ currents and IP3-mediated Ca2+ release in AV node depolarization. Combining calcium imaging with electrophysiology provides a comprehensive view of excitation-contraction coupling.
Transcriptomics and proteomics
RNA-seq and proteomics can identify the repertoire of ion channels, receptors, and signaling molecules expressed in AV node cells, helping to pinpoint genes relevant to GO:0086045. Comparative analyses between AV node and working myocardium reveal tissue-specific depolarization mechanisms. These datasets can guide CRISPR target selection.
How CRISPR Can Be Used to Study GO:0086045 membrane depolarization during AV node cell action potential
Knockout
CRISPR knockout of candidate genes such as CACNA1C, HCN4, or ITPR1 in iPSC-derived AV node-like cardiomyocytes can determine whether they are required for depolarization. Loss-of-function models reveal essential contributors and compensatory mechanisms. Knockout mice for these genes can also be used, though species differences in AV node electrophysiology must be considered.
Point Mutation
Introducing patient-specific point mutations (e.g., in SCN5A or KCNH2) via CRISPR base editing or homology-directed repair allows precise testing of variant effects on AV node depolarization. These models are valuable for understanding inherited arrhythmia syndromes and for drug screening.
Knock-in
Knock-in of reporter tags (e.g., fluorescent proteins) or epitope tags into endogenous loci such as HCN4 or CACNA1C enables real-time tracking of channel localization and function in AV node cells. This approach can also be used to introduce human disease alleles into animal models.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like HCN4 or KCNQ1 can enhance or suppress AV node depolarization, providing gain-of-function models. These are useful for testing whether increasing a specific current can rescue conduction defects or create a biological pacemaker.
How EDITGENE Supports membrane depolarization during AV node cell action potential Research
Researchers studying membrane depolarization during AV node cell action potential-related genes often need to determine whether a candidate gene is causally involved in this process. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models, enabling functional validation of genes implicated in AV node electrophysiology.
Contact EDITGENE today to design your custom CRISPR model for membrane depolarization during AV node cell action potential research.
Frequently Asked Questions About membrane depolarization during AV node cell action potential
What is GO:0086045?
GO:0086045 is a Gene Ontology biological process term defined as the process in which AV node cardiac muscle cell membrane potential changes in the depolarizing direction from the negative resting potential towards the positive membrane potential that will be the peak of the action potential.
What genes are involved in membrane depolarization during AV node cell action potential?
Key genes include CACNA1C, CACNA1D, CACNA1G, CACNA1H (calcium channels), HCN4 (pacemaker channel), SCN5A (sodium channel), and ITPR1/ITPR2 (IP3 receptors).
Why is AV node depolarization important?
The AV node is the only normal electrical connection between atria and ventricles, so its depolarization determines conduction velocity and heart rate; dysfunction causes AV block and arrhythmias.
How is AV node depolarization different from ventricular depolarization?
AV node cells lack a large fast sodium current and instead rely on slow inward calcium currents, resulting in slower depolarization and conduction.
What diseases are associated with abnormal AV node depolarization?
Diseases include atrioventricular block, Wenckebach periodicity, AV nodal reentrant tachycardia, and inherited conduction disorders linked to SCN5A or HCN4 mutations.
How can I study AV node depolarization in the lab?
Common methods include patch-clamp electrophysiology, optical mapping, calcium imaging, and CRISPR-based genetic manipulation in iPSC-derived cardiomyocytes.
What is the role of IP3 in AV node depolarization?
IP3 signaling can modulate the spontaneous action potential rate in AV node myocytes, linking intracellular calcium release to depolarization.
Can CRISPR be used to study AV node depolarization genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes in AV node-like cells.
What are the synonyms for GO:0086045?
Synonyms include membrane depolarization during atrioventricular node cardiac muscle cell action potential and membrane depolarization during AV node cardiac muscle cell action potential.
Which ion channels mediate the AV node action potential upstroke?
The upstroke is primarily mediated by L-type and T-type calcium channels, with minor contributions from other currents.
Conclusion
GO:0086045, membrane depolarization during AV node cell action potential, is a precisely defined biological process that is central to cardiac conduction. Its unique ionic mechanisms, primarily relying on slow calcium currents, distinguish AV node cells from working myocardium and make them a critical target for understanding and treating arrhythmias. Dysregulation of this process underlies AV block, reentrant tachycardias, and inherited conduction disorders. Advances in CRISPR-based genome editing and iPSC-derived cardiac models now enable rigorous functional dissection of the genes and pathways controlling AV node depolarization. By combining electrophysiology, imaging, and multi-omics with precise genetic models, researchers can uncover new therapeutic targets and improve clinical management of conduction diseases. EDITGENE's services support these efforts by providing custom-engineered cell and animal models tailored to AV node research.
References
- 1. Tosaki A. 2020. ArrhythmoGenoPharmacoTherapy.. Front Pharmacol 11:616 PMID: 32477118
- 2. Wit AL et al.. 1983. Pathophysiologic mechanisms of cardiac arrhythmias.. Am Heart J 106(4 Pt 2):798-811 PMID: 6310978
- 3. Cheng H et al.. 2024. Modulation of Spontaneous Action Potential Rate by Inositol Trisphosphate in Myocytes from the Rabbit Atrioventricular Node.. Cells 13(17) PMID: 39273026
- 4. Perry RS et al.. 1986. Basic cardiac electrophysiology and mechanisms of antiarrhythmic agents.. Am J Hosp Pharm 43(4):957-74 PMID: 2871752
- 5. Kokubun S et al.. 1980. The spontaneous action potential of rabbit atrioventricular node cells.. Jpn J Physiol 30(4):529-40 PMID: 7463865
- 6. Simon-Chica A et al.. 2022. Novel insights into the electrophysiology of murine cardiac macrophages: relevance of voltage-gated potassium channels.. Cardiovasc Res 118(3):798-813 PMID: 33823533
- 7. Zhang Y et al.. 2011. AV nodal dual pathway electrophysiology and Wenckebach periodicity.. J Cardiovasc Electrophysiol 22(11):1256-62 PMID: 21489031
- 8. Kokubun S et al.. 1982. Membrane currents in the rabbit atrioventricular node cell.. Pflugers Arch 393(1):15-22 PMID: 6283467
